Bariatric surgery versus conventional medical therapy for type 2 diabetes
- PMID: 22449317
- DOI: 10.1056/NEJMoa1200111
Bariatric surgery versus conventional medical therapy for type 2 diabetes
Abstract
Background: Roux-en-Y gastric bypass and biliopancreatic diversion can markedly ameliorate diabetes in morbidly obese patients, often resulting in disease remission. Prospective, randomized trials comparing these procedures with medical therapy for the treatment of diabetes are needed.
Methods: In this single-center, nonblinded, randomized, controlled trial, 60 patients between the ages of 30 and 60 years with a body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) of 35 or more, a history of at least 5 years of diabetes, and a glycated hemoglobin level of 7.0% or more were randomly assigned to receive conventional medical therapy or undergo either gastric bypass or biliopancreatic diversion. The primary end point was the rate of diabetes remission at 2 years (defined as a fasting glucose level of <100 mg per deciliter [5.6 mmol per liter] and a glycated hemoglobin level of <6.5% in the absence of pharmacologic therapy).
Results: At 2 years, diabetes remission had occurred in no patients in the medical-therapy group versus 75% in the gastric-bypass group and 95% in the biliopancreatic-diversion group (P<0.001 for both comparisons). Age, sex, baseline BMI, duration of diabetes, and weight changes were not significant predictors of diabetes remission at 2 years or of improvement in glycemia at 1 and 3 months. At 2 years, the average baseline glycated hemoglobin level (8.65±1.45%) had decreased in all groups, but patients in the two surgical groups had the greatest degree of improvement (average glycated hemoglobin levels, 7.69±0.57% in the medical-therapy group, 6.35±1.42% in the gastric-bypass group, and 4.95±0.49% in the biliopancreatic-diversion group).
Conclusions: In severely obese patients with type 2 diabetes, bariatric surgery resulted in better glucose control than did medical therapy. Preoperative BMI and weight loss did not predict the improvement in hyperglycemia after these procedures. (Funded by Catholic University of Rome; ClinicalTrials.gov number, NCT00888836.).
Comment in
-
Surgery or medical therapy for obese patients with type 2 diabetes?N Engl J Med. 2012 Apr 26;366(17):1635-6. doi: 10.1056/NEJMe1202443. Epub 2012 Mar 26. N Engl J Med. 2012. PMID: 22449318 No abstract available.
-
Diabetes: On trial--bariatric surgery for treatment of type 2 diabetes mellitus.Nat Rev Endocrinol. 2012 Apr 10;8(6):317. doi: 10.1038/nrendo.2012.57. Nat Rev Endocrinol. 2012. PMID: 22488643 No abstract available.
-
ACP Journal Club. Gastric bypass or biliopancreatic diversion increases remission from type 2 diabetes in obese adults.Ann Intern Med. 2012 Jul 17;157(2):JC2-12. doi: 10.7326/0003-4819-157-2-201207170-02012. Ann Intern Med. 2012. PMID: 22801703 No abstract available.
-
Bariatric surgery or medical therapy for obesity.N Engl J Med. 2012 Aug 2;367(5):473; author reply 474-6. doi: 10.1056/NEJMc1206633. N Engl J Med. 2012. PMID: 22853019 No abstract available.
-
Bariatric surgery or medical therapy for obesity.N Engl J Med. 2012 Aug 2;367(5):473-4; author reply 474-6. doi: 10.1056/NEJMc1206633. N Engl J Med. 2012. PMID: 22853020 No abstract available.
-
Bariatric surgery or medicine for type 2 diabetes?Expert Opin Pharmacother. 2012 Oct;13(15):2249-53. doi: 10.1517/14656566.2012.721779. Epub 2012 Sep 8. Expert Opin Pharmacother. 2012. PMID: 22957791
-
[Bariatric surgery versus conventional medical therapy for type 2 diabetes].Rev Clin Esp. 2012 Oct;212(9):461. doi: 10.1016/j.rce.2012.05.020. Rev Clin Esp. 2012. PMID: 23213657 Spanish. No abstract available.
-
An obesity remedy for diabetes.J Fam Pract. 2013 Jan;62(1):30-2. J Fam Pract. 2013. PMID: 23326820 Free PMC article.
-
The surgical cure for diabetes?Natl Med J India. 2012 Sep-Oct;25(5):281-3. Natl Med J India. 2012. PMID: 23448628 No abstract available.
-
[Bariatric surgery and diabetes mellitus: pioneering studies from 2012 and consequences for treatment strategies].Internist (Berl). 2013 May;54(5):639-44. doi: 10.1007/s00108-013-3274-z. Internist (Berl). 2013. PMID: 23568061 German. No abstract available.
-
Update in endocrinology: evidence published in 2012.Ann Intern Med. 2013 Jun 4;158(11):821-4. doi: 10.7326/0003-4819-158-11-201306040-00106. Ann Intern Med. 2013. PMID: 23580066 No abstract available.
Similar articles
-
Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.Lancet. 2015 Sep 5;386(9997):964-73. doi: 10.1016/S0140-6736(15)00075-6. Lancet. 2015. PMID: 26369473 Clinical Trial.
-
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.N Engl J Med. 2017 Feb 16;376(7):641-651. doi: 10.1056/NEJMoa1600869. N Engl J Med. 2017. PMID: 28199805 Free PMC article. Clinical Trial.
-
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.N Engl J Med. 2014 May 22;370(21):2002-13. doi: 10.1056/NEJMoa1401329. Epub 2014 Mar 31. N Engl J Med. 2014. PMID: 24679060 Free PMC article. Clinical Trial.
-
Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.Ann Surg. 2015 Mar;261(3):459-67. doi: 10.1097/SLA.0000000000000863. Ann Surg. 2015. PMID: 25361217 Review.
-
Surgery for weight loss in adults.Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4. Cochrane Database Syst Rev. 2014. PMID: 25105982 Free PMC article. Review.
Cited by
-
Metabolic/Bariatric Surgery is Safe and Effective in People with Obesity, Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Obes Surg. 2024 Nov;34(11):4097-4105. doi: 10.1007/s11695-024-07535-4. Epub 2024 Oct 17. Obes Surg. 2024. PMID: 39417958
-
Comparative effectiveness of metabolic and bariatric surgeries: a network meta-analysis.Int J Obes (Lond). 2025 Jan;49(1):54-62. doi: 10.1038/s41366-024-01648-7. Epub 2024 Oct 14. Int J Obes (Lond). 2025. PMID: 39397157 Review.
-
Prognostic Characteristics of Metabolic Dysfunction-Associated Steatotic Liver in Patients with Obesity Who Undergo One Anastomosis Gastric Bypass Surgery: A Secondary Analysis of Randomized Controlled Trial Data.Nutrients. 2024 Sep 23;16(18):3210. doi: 10.3390/nu16183210. Nutrients. 2024. PMID: 39339810 Free PMC article. Clinical Trial.
-
Relationship between Body Adiposity Indices and Reversal of Metabolically Unhealthy Obesity 6 Months after Roux-en-Y Gastric Bypass.Metabolites. 2024 Sep 18;14(9):502. doi: 10.3390/metabo14090502. Metabolites. 2024. PMID: 39330509 Free PMC article.
-
Analysis of long-term outcome of modified gastric bypass for type 2 diabetes mellitus in Chinese patients.World J Clin Cases. 2024 Sep 6;12(25):5697-5705. doi: 10.12998/wjcc.v12.i25.5697. World J Clin Cases. 2024. PMID: 39247739 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials